Thiazolyl mGluR5 antagonists and methods for their use
Details for Australian Patent Application No. 2005336513 (hide)
International Classifications
Event Publications
17 May 2007 Application Open to Public Inspection
Published as AU-B-2005336513
17 May 2007 PCT application entered the National Phase
PCT publication WO2007/050050 Priority application(s): WO2007/050050
8 January 2009 Corrigenda
PCT applications that have entered the National Phase - Name Index Under the Name Merck & Co., Inc., Application No. 2005336513, under INID (43) correct the date to 3 May 2007 Corrigenda
28 January 2010 Alteration of Name
The name of the applicant has been altered to Merck Sharp & Dohme Corp. 2006
9 August 2012 Application Accepted
Published as AU-B-2005336513
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005336514-TORC polynucleotides and polypeptides, and methods of use
2005336512-Feed mechanism for maintaining constant web tension in a wide format printer
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser